Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Witzel

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Neurology|August 9, 2022
Biomarkers for amyotrophic lateral sclerosisSimon Witzel, Kristina Mayer, Patrick Oeckl
JACC. Cardiovascular Imaging|July 7, 2018
Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled TrialDominik Buckert, Simon Witzel, Jürgen M Steinacker, et al.
Trials|July 30, 2017
Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trialDominik Buckert, Simon Witzel, Maciej Cieslik, et al.
European Journal of Neurology|September 28, 2022
Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosisKailin Xia, Simon Witzel, Christina Witzel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 13, 2022
Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled studyJohannes Dorst, Judith Doenz, Katharina Kandler, et al.
Scientific Reports|January 9, 2025
Hypothalamic atrophy in primary lateral sclerosis, assessed by convolutional neural network-based automatic segmentationJan Kassubek, Francesco Roselli, Simon Witzel, et al.
European Journal of Neurology|November 17, 2023
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagilineSimon Witzel, Jeffrey M Statland, Petra Steinacker, et al.
Journal of Neurology|November 22, 2018
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patientsClaudia D Wurster, Benedikt Winter, Kurt Wollinsky, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
Frontiers in Immunology|August 7, 2023
Low T-cell reactivity to TDP-43 peptides in ALSSwetha Ramachandran, Veselin Grozdanov, Bianca Leins, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Neurology|August 9, 2022
Biomarkers for amyotrophic lateral sclerosisSimon Witzel, Kristina Mayer, Patrick Oeckl
JACC. Cardiovascular Imaging|July 7, 2018
Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled TrialDominik Buckert, Simon Witzel, Jürgen M Steinacker, et al.
Trials|July 30, 2017
Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trialDominik Buckert, Simon Witzel, Maciej Cieslik, et al.
European Journal of Neurology|September 28, 2022
Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosisKailin Xia, Simon Witzel, Christina Witzel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 13, 2022
Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled studyJohannes Dorst, Judith Doenz, Katharina Kandler, et al.
Scientific Reports|January 9, 2025
Hypothalamic atrophy in primary lateral sclerosis, assessed by convolutional neural network-based automatic segmentationJan Kassubek, Francesco Roselli, Simon Witzel, et al.
European Journal of Neurology|November 17, 2023
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagilineSimon Witzel, Jeffrey M Statland, Petra Steinacker, et al.
Journal of Neurology|November 22, 2018
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patientsClaudia D Wurster, Benedikt Winter, Kurt Wollinsky, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
Frontiers in Immunology|August 7, 2023
Low T-cell reactivity to TDP-43 peptides in ALSSwetha Ramachandran, Veselin Grozdanov, Bianca Leins, et al.
Pageof 4